A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation

Therapeutic Drug Monitoring

Volumn 20, Issue 4, 1998, Pages 401-407

  Meier Kriesche, Herwig Ulf ^a   Kaplan, Bruce ^a   Brannan, Patricia ^a   Kahan, Barry D ^a   Portman, Ronald J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Abbreviated; Area under the curve (AUC); Neoral; Pharmacokinetics

Indexed keywords

CYCLOSPORIN A;

AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG MONITORING; EMULSIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0031874107     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199808000-00009     Document Type: Article

References (21)

1. Williams AW, Morgenstern BZ, Murphy M, Milliner DS. Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients. Pediatr Nephrol 1994;8:566-9.
2. Chavers BM, Matas AJ, Gillingham KJ, Schmidt WJ, Najarian JS. Pediatric renal transplantation at the University of Minnesota: the cyclosporine years. Clin Transplant 1994;203-12.
3. McDonald RA, Watkins SL. Progress in renal transplantation for children. Adv Ren Replace Ther 1996;3:60-8.
4. Tejani A, Sullivan EK. Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1996;7:550-5.
5. Bokenkamp A, Offner G, Hoyer PF, Vester U, Wonigeit K, Brodehl J. Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring. Pediatr Nephrol 1995;9:196-8.
6. Barone G, Chang CT, Choc MG, et al. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients: the Neoral Study Group. Transplantation 1996; 61:875-80.
7. Mueller EA, Kallay Z, Kovarik JM, et al. Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients. Transplantation 1995;60:515-7.
8. Kovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz K. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994;83:444-6.
9. Kahan BD, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995;59:505-11.
10. Kovarik JM, Mueller EA, van Bree JB, Arns W, Renner E, Kutz K. Within-day consistency in cyclosporine pharmacokinetics from a microemulsion formulation in renal transplant patients. Ther Drug Monit 1994;16:232-7.
11. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993;54:205-18.
12. Ohlman S, Lindholm A, Hagglund H, Sawe J, Kahan BD. On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation. Eur J Clin Pharmacol 1993; 44:265-9.
13. Lindholm A. Cyclosporine A: clinical experience and therapeutic drug monitoring. Ther Drug Monit 1995;17:631-7.
14. Kahan BD, Grevel J. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 1988;46:631-44.
15. Kovarik JM, Mueller EA, van Bree JB, et al. Cyclosporine pharmacokinetics and variability from a microemulsion formulation - a multicenter investigation in kidney transplant patients. Transplantation 1994;58:658-63.
16. Amante AJ, Meier-Kriesche H-U, Schoenberg L, Kahan BD. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporine used de novo after renal transplantation. Transpl Int 1997;10:217-22
17. Amante AJ, Kahan BD. Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period. Clin Chem 1996;42:1294-6.
18. Portman R, Medhi N, Brannan D, et al. Abbreviated cyclosporine pharmacokinetic study for management of Neoral dosing in pediatric kidney transplant patients [abstract]. J Am Soc Nephrol 1996; 7:1919.
19. Ritschel WA. Handbook of Basic Pharmacokinetics. 4th ed. Hamilton IL: Drug Intelligence Publications; 1992:356.
20. Norusis MJ. SPSS for Windows: Advanced Statistics, Users Guide (version 6.0). Chicago: SPSS Inc; 1993:311.
21. Lindholm A, Welsh M, Rutzky L, Kahan BD. The adverse impact of high cyclosporine: clearance rates on the incidences of acute rejection and graft loss. Transplantation. 1993:55:985-93.